Home LiteratureArticle Details
PMID: 12805466 Published · ppublish English Journal Article

Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene.

Journal of virology ·Vol. 77 ·No. 13 ·2003-07-00 ·Pages 7663-8

Casimiro DR, Tang A, Chen L, Fu TM, Evans RK, Davies ME, Freed DC, Hurni W, Aste-Amezaga JM, Guan L, Long R, Huang L, Harris V, Nawrocki DK, Mach H, Troutman RD, Isopi LA, Murthy KK, Rice K, Wilson KA, Volkin DB, Emini EA, Shiver JW

Abstract

The cellular immunogenicity of formulated plasmid DNA and replication-defective human adenovirus serotype 5 (Ad5) vaccine vectors expressing a codon-optimized human immunodeficiency virus type 1 gag gene was examined in baboons. The Ad5 vaccine was capable of inducing consistently strong, long-lived CD8(+)-biased T-cell responses and in vitro cytotoxic activities. The DNA vaccine-elicited immune responses were weaker than those elicited by the Ad5 vaccine and highly variable; formulation with chemical adjuvants led to moderate increases in the levels of Gag-specific T cells. Increasing the DNA-primed responses with booster doses of either Ad5 or modified vaccinia virus Ankara vaccines suggests a difference in the relative levels of cytotoxic and helper responses. The implications of these results are discussed.

MeSH Terms
AIDS Vaccines/administration & dosage,immunology Adenoviridae/genetics,immunology Animals Defective Viruses/genetics,immunology Dose-Response Relationship, Immunologic Genes, gag HIV-1/genetics Papio T-Lymphocytes/immunology
Chemicals
AIDS Vaccines
Authors & Affiliations
23 authors, click to expand affiliations / ORCID
Casimiro Danilo R
Department of Viral Vaccine Research, Merck Research Laboratories, West Point, Pennsylvania 19486, USA. danilo_casimiro@merck.com
Tang Aimin
Chen Ling
Fu Tong-Ming
Evans Robert K
Davies Mary-Ellen
Freed Daniel C
Hurni William
Aste-Amezaga Jose M
Guan Liming
Long Romnie
Huang Lingyi
Harris Virginia
Nawrocki Denise K
Mach Henryk
Troutman Robert D
Isopi Lynne A
Murthy Krishna K
Rice Karen
Wilson Keith A
Volkin David B
Emini Emilio A
Shiver John W
References (29)
29 references, click to expand
  1. Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.
    J Virol. 2000 Mar;74(6):2740-51 PMID: 10684290
  2. Differential expression of natural killer cell markers: human versus baboon.
    Transplantation. 1996 Nov 15;62(9):1319-24 PMID: 8932279
  3. Evaluation of cytotoxic T-lymphocyte responses in human and nonhuman primate subjects infected with human immunodeficiency virus type 1 or simian/human immunodeficiency virus.
    J Virol. 2001 Jan;75(1):73-82 PMID: 11119575
  4. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
    Science. 2001 Apr 6;292(5514):69-74 PMID: 11393868
  5. Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development.
    Immunol Rev. 2001 Oct;183:127-40 PMID: 11782253
  6. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
    Nature. 2002 Jan 17;415(6869):331-5 PMID: 11797011
  7. Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccines.
    J Virol. 2002 Oct;76(19):10038-43 PMID: 12208982
  8. Overcoming immunity to a viral vaccine by DNA priming before vector boosting.
    J Virol. 2003 Jan;77(1):799-803 PMID: 12477888
  9. Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SIVmac251-infected macaques.
    Virology. 2002 Dec 5;304(1):125-34 PMID: 12490410
  10. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene.
    J Virol. 2003 Jun;77(11):6305-13 PMID: 12743287
  11. Synthetic oligonucleotide probes deduced from amino acid sequence data. Theoretical and practical considerations.
    J Mol Biol. 1985 May 5;183(1):1-12 PMID: 4009718
  12. Effect of dose and immunization schedule on immune response of baboons to recombinant glycoprotein 120 of HIV-1.
    J Infect Dis. 1989 Dec;160(6):960-9 PMID: 2555423
  13. Antibodies are produced to the variable regions of the external envelope glycoprotein of human immunodeficiency virus type 1 in chimpanzees infected with the virus and baboons immunized with a candidate recombinant vaccine.
    J Gen Virol. 1992 May;73 ( Pt 5):1099-106 PMID: 1375277
  14. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    J Virol. 1994 Jul;68(7):4650-5 PMID: 8207839
  15. Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primates.
    J Virol. 1994 Aug;68(8):5036-44 PMID: 8035504
  16. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
    J Virol. 1994 Sep;68(9):6103-10 PMID: 8057491
  17. An AIDS-like condition induced in baboons by HIV-2.
    Science. 1994 Oct 28;266(5185):642-6 PMID: 7939718
  18. Infection of baboons with simian/human immunodeficiency viruses.
    J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 15;9(5):429-41 PMID: 7627620
  19. Applications of pox virus vectors to vaccination: an update.
    Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11349-53 PMID: 8876138
  20. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.
    Science. 1997 Nov 21;278(5342):1447-50 PMID: 9367954
  21. Infection of baboons with a simian immunodeficiency virus/HIV-1 chimeric virus constructed with an HIV-1 Thai subtype E envelope.
    AIDS. 1998 May 28;12(8):849-57 PMID: 9631137
  22. Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells.
    Curr Opin Immunol. 1998 Aug;10(4):444-9 PMID: 9722921
  23. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression.
    Cytometry. 1998 Oct 15;34(5):207-15 PMID: 9822306
  24. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
    Science. 1999 Feb 5;283(5403):857-60 PMID: 9933172
  25. Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing response.
    J Pharm Sci. 1998 Dec;87(12):1489-95 PMID: 10189254
  26. Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors.
    Immunol Lett. 1999 Mar;66(1-3):9-14 PMID: 10203028
  27. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.
    J Virol. 1999 Sep;73(9):7524-32 PMID: 10438842
  28. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge.
    J Virol. 1999 Oct;73(10):8356-63 PMID: 10482586
  29. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.
    J Virol. 2000 Sep;74(18):8541-9 PMID: 10954555
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2003-07-00
Pages
7663-8
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC164828
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com